학술논문
Efficacy and safety of imeglimin monotherapy versus placebo in japanese patients with type 2 diabetes (Times 1): A double-blind, randomized, placebo-controlled, parallel-group, multicenter phase 3 trial
Document Type
Article
Author
Source
In: Diabetes Care . (Diabetes Care, 2021, 44(4):952-959)
Subject
Language
English
ISSN
19355548
01495992
01495992